JFL Life Sciences, an Indian pharmaceutical company, manufactures diverse products including injections, tablets and ORS. They've secured a domestic order from Brihanmumbai Municipal Corporation, valued at ₹11.95 crore (including taxes), for injections and sera vaccines. This contract is for pharmaceutical/life-care/healthcare product supply, to be executed between June 16, and June 2027.